S6 Ep17: Dr. Fran Gregory's Sizes Up the US Adalimumab Market: Will Biosimilars See Success?

Not So Different: A Podcast from The Center for Biosimilars

To read more about Dr. Gregory's commentary piece, click here.
To read more about Cardinal Health's 2023 Biosimilars Report, click here.
To learn more about adalimumab biosimilars, click here.
To learn more about the adalimumab biosimilars that have launched so far in the US:

• Click here for the launch of Amjevita
• Click here for the launches of Hyrimoz, Hadlima, Yusimry, and Cyltezo
• Click here for the launch of Yuflyma
• Click here for the launches of Idacio and Hulio